The 2026 Alzheimer’s clinical trials pipeline shows a strategic shift from amyloid to inflammation and tau targets, with combination therapies and repurposed drugs leading the way. In 2026, the Alzh...
New study shows lifestyle factors have three times greater impact on survival past 80 than genetic predisposition. A landmark study reveals that healthy habits outweigh genes for living longer, even i...
A March 2025 study in Cell Reports Medicine finds that muscle loss from GLP-1 drugs mirrors ordinary weight loss, alleviating public concern. A new study reassures that GLP-1 drugs do not cause dispro...
New research links inflammaging and immunosenescence to Alzheimer’s and Parkinson’s, with immune-modulating therapies showing early promise. Aging of the immune system accelerates brain di...
Explore how partial reprogramming using Yamanaka factors reverses epigenetic aging, with recent advances in mice and early clinical trials paving the way for rejuvenation therapies. Partial reprogramm...
A major study reveals aging is a coordinated epigenetic program, not random damage. Single-cell ATAC-seq of 7 million cells shows stereotyped changes across organs, with therapeutic implications. New ...
Recent studies reveal that immune aging, or ‘inflammaging,’ is a modifiable risk factor for neurodegenerative diseases, with new biomarkers and senolytic drugs offering hope for early inte...
A new study in Aging Cell uncovers a bidirectional feedback loop between intestinal aging and gut microbiome changes, accelerating systemic inflammation. A study in Aging Cell reveals how age-related ...
New research links eusociality to extreme longevity, revealing mechanisms like hyaluronic acid and epigenetic reprogramming that could inspire human anti-aging therapies. Eusocial species live excepti...
New research reveals an inverse relationship between cancer and neurodegenerative diseases, offering evolutionary insights for dual therapies targeting healthy aging. Could the same biological pathway...
